Cargando…
Talaromycosis in a Patient on Nintedanib for Interstitial Lung Disease
Talaromycosis is a fungal infection caused by Talaromyces sp. that is predominantly prevalent in patients with acquired immunodeficiency syndrome in the United States. It is also rarely seen in other individuals who are otherwise immunosuppressed. With the advent of immunotherapy and increasing usag...
Autores principales: | Madgula, Anantha Sriharsha, Covello, Brian R, Singh, Meghana, Rao, Arundati, Lee, Jim C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141794/ https://www.ncbi.nlm.nih.gov/pubmed/32274273 http://dx.doi.org/10.7759/cureus.7215 |
Ejemplares similares
-
Systemic Sclerosis Associated Interstitial Lung Disease and Nintedanib: A Rare Disease and a Promising Drug
por: Kafle, Sunam, et al.
Publicado: (2021) -
A Rare Case of Statin-induced Immune-mediated Necrotizing Myopathy
por: Madgula, Anantha Sriharsha, et al.
Publicado: (2020) -
Radiation-Induced Lung Injury With Lung Cancer Treated With the Combination Therapy of Nintedanib and Dexamethasone
por: Itano, Junko, et al.
Publicado: (2023) -
Ventricular Tachycardia Storm in a Patient Treated With Ibrutinib for Waldenstrom Macroglobulinemia
por: Madgula, Anantha Sriharsha, et al.
Publicado: (2020) -
Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study
por: Liang, Junyu, et al.
Publicado: (2021)